Base title: NCI's genomic characterization center to title: DNA whole exome sequencing (WXS) for new CCG studies period of performance 07/27/2020 - 07/26/2023 fully funded - non-severable services
Ended Awarded Last action
- Contract number
- 75N91020F00001
- Awardee
-
Azenta US Inc. UEI FW1MQC5H7K56 Part of Azenta, Inc.
- Awarding agency
-
National Cancer Institute
National Institutes of Health, Department of Health and Human Services
- Obligated
- $479,145
Award facts
- Opportunity
-
- GCCTSB42320 Solicitation number
- Contract value 100% obligated
- $479,145.00 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 541990 All Other Professional, Scientific, and Technical Services
- Set-aside
- No set-aside
- Competition
- Full and Open Competition · 5 offers Multiple Award, Fair Opportunity
- Pricing
- Firm Fixed Price
- Place of performance
- South Plainfield, NJ 07080, USA
- Legislative mandates
-
- Employment Eligibility Verification (E-Verify) FAR subpart 22.18
- Service Contract Inventory FAR subpart 4.17
Award details come from SAM.gov/FPDS.
Transactions
| Action | Obligated | Date |
|---|---|---|
| Supplemental Agreement for work within scope | -$999,855 | |
| Other Administrative Action | $0 | |
| Original award | $1,479,000 |
About this award
This is a firm fixed-price delivery order contract awarded by the National Cancer Institute (NCI) to Azenta US Inc., doing business as Brooks Life Sciences Inc., for DNA whole exome sequencing services to support new studies under the NCI's Childhood Cancer Data Initiative. The period of performance is from July 27, 2020 to July 26, 2023, with a total ceiling value of $479,145. This contract is part of the NCI Genomic Characterization Centers contract vehicle, a larger indefinite delivery/indefinite quantity (IDIQ) contract. The contract is not set aside for any specific business category. Azenta US Inc. is a subsidiary of the parent company Azenta, Inc., which has a history of providing life sciences solutions and services to various federal agencies.
Quick answers
Who was awarded contract 75N91020F00001?
75N91020F00001 was awarded to Azenta US Inc. by National Cancer Institute (National Institutes of Health) on July 27, 2020.
How much is contract 75N91020F00001 worth?
The government has obligated $479,145 on 75N91020F00001.
Is contract 75N91020F00001 an order under another contract?
Yes. 75N91020F00001 is a delivery order under 75N91019D00030, an indefinite delivery contract, on NCI Genomic Characterization Centers.
Was contract 75N91020F00001 competed?
The extent of competition for 75N91020F00001 was full and open competition. The government received 5 offers.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award